Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CannPal Animal

PUBLIC STATUS
CP1 STOCK SYMBOL
$0.16 SHARE PRICE (As of Friday Closing)
Description

Operator of a pet pharmaceutical company. The company's business includes providing veterinarians with regulatory approved, cannabinoid-based pharmaceuticals.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ASX
Primary Office
  • Level 3, 43a Bay Street
  • Double Bay
  • Sydney, New South Wales 2028
  • Australia

+61 (02) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CannPal Animal’s full profile, request a free trial.

CannPal Animal Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.12 - $0.23 $14.8M $0.17 123K 93.1M

CannPal Animal Financials Summary

In Thousands,
USD
FY 2017
31-Mar-2017
Total Assets 5,019
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CannPal Animal Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore CannPal Animal‘s full profile, request access.

Request full access to PitchBook

CannPal Animal Executive Team (1)

Name Title Board
Seat
Contact
Info
Layton Mills Co-Founder & Managing Director